Cognitive Behavioural Therapy for Acute Insomnia Disorder
Evaluation of Analytic-integrative Cognitive Behavioural Therapy for Acute Insomnia Disorder (Stress)
This study tests if a special type of therapy can help people with insomnia caused by stress get better sleep without using medication.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 70 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Xuanwu Hospital, Beijing Academic / other |
| Locations | 1 site (Beijing) |
| Trial ID | NCT06967922 on ClinicalTrials.gov |
What this trial studies
This study investigates the effectiveness of Analytic-Integrative Cognitive Behavioural Therapy (CBT) in treating acute insomnia disorder caused by stress. It focuses on patients who experience difficulties with sleep onset and maintenance due to stressful life events. The approach aims to correct negative sleep cognition and habits while improving overall mental health without the adverse effects associated with medications. Participants will receive individualized treatment plans based on their specific situations to enhance therapeutic outcomes.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who meet the DSM-5 criteria for insomnia disorder and have a PSQI score greater than 5.
Not a fit: Patients with serious physical or mental illnesses, sleep breathing disorders, or those currently undergoing psychological treatment may not benefit from this study.
Why it matters
Potential benefit: If successful, this therapy could provide a safe and effective non-pharmacological treatment option for patients suffering from acute insomnia disorder.
How similar studies have performed: Previous studies have shown that cognitive behavioural therapy is effective for insomnia, indicating a promising approach for this specific population.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. meeting the DSM-5 diagnostic criteria for insomnia disorder; 2. a total score of \>5 on the Pittsburgh Sleep Quality Index (PSQI); 3. age ≥18 years old, with junior high school education or above; 4. voluntarily participating in this study and signing an informed consent form; 5. the diagnostic criteria for acute insomnia disorder (duration of the disease less than 3 months). Exclusion Criteria: 1. people with comorbid serious physical or severe mental illnesses, suicide risk; 2. clinically diagnosed or suspected sleep breathing disorder, restless legs syndrome and sleep-wake rhythm disorder, shift workers; 3. pregnant and breastfeeding women; 4. people who are currently undergoing any psychological treatment.
Where this trial is running
Beijing
- Xuanwu Hospital, Capital Medical University — Beijing, China (Recruiting)
Study contacts
- Study coordinator: Hongxing Wang, MD & PhD
- Email: wanghongxing@xwh.ccmu.edu.cn
- Phone: +86 13911127385
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.